CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Exercise or conversion Chief Scientific Officer acquired 7,218 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 1,400 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $67.71 ($203,135)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $66.57 ($665,747)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $64.16 ($641,615)
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $67.68 ($203,032)
- 4 Open-market sale Chief Commercial Officer sold 10,000 shares at an average $67.01 ($670,050)
- 4 Open-market sale Chief Scientific Officer sold 9,000 shares at $65.00 ($585,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 18 of 38 · 758 filings